Allogeneic hematopoietic stem cell transplantation in patients 50 years of age and older
Rafael de la Cámara(Hospital Universitario de La Princesa), José María Fernández‐Rañada, Valle Gómez de Soria, Juan Luis Steegmann(Hospital Universitario de La Princesa), Enrique Granados(Spanish Society of Hematology and Hemotherapy), Á Figuera(Hospital Universitario de La Princesa), Reyes Arranz, Gabriela Rodríguez‐Macías, Arancha Alonso, César Sanz-Rodrı́guez(Merck Biopharma Co., Ltd. (Japan))
Cited by 16
Related Papers
A New Prognostic Score for Survival of Patients With Chronic Myeloid Leukemia Treated With Interferon Alfa Writing Committee for the Collaborative CML Prognostic Factors Project Group
|JNCI Journal of the National Cancer Institute|1998|820
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
|Leukemia|2016|473
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
|New England Journal of Medicine|2019|464